# Regional Business Director (RBD) RayzeBio- Northeast Region — Bristol Myers Squibb

- Location: Field - United States - US
- Posted pay: $244k–$296k/yr
- Posted: Nov 13, 2026
- Status: open (checked Nov 22, 2026)
- Apply (employer's site): https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Field---United-States---US/Regional-Business-Director--RBD--RayzeBio--Northeast-Region_R1608415-1
- Employer record: https://visajobs.io/company/bristol-myers-squibb.md

## Sponsorship history
- Tier: Good history
- Occupation (SOC): Data Scientists (15-2051)
- …in the whole US: 135
- With this exact title: 0
- Median DOL prevailing wage, level I / II: $75k / $98k

## Description
Life at BMS
At RayzeBio, every day is an opportunity to ignite meaningful change. As a wholly-owned subsidiary of Bristol Myers Squibb, RayzeBio blends the nimble, pioneering spirit of an emergent biotech with the global expertise and resources of a leading innovator in oncology. Our mission is to develop transformative radiopharmaceutical therapies that offer new hope for patients living with cancer. Here, you’ll join a multidisciplinary team where your ideas are valued, your expertise is amplified, and collaboration is at the heart of everything we do. From day one, expect to make an immediate impact—on our science, on our teams, and most importantly, on patients. Learn more about RayzeBio: https://careers.bms.com/rayzebio/
The Regional Business Director (RBD) - Northeast Region is a sales leader with a mindset of owning the region's business, accountable for demand generation, account engagement, site readiness, and referral performance across RYZ101's regional footprint. The RBD leads a team of 6 to 9 RPT Territory Managers (RTMs), orchestrating across Site Readiness and referral pathways to convert territory-level demand into scheduled, dosed patients. Must be based in the Northeast region of the US.
Key Responsibilities
Regional Business Ownership
Own overall regional performance for RYZ101, including demand generation, referral conversion, and dosing volume against regional targets
Personally own account planning for business-critica
l accounts within the region, maintaining direct relationships with priority treatment centers rather than delegating solely to RTMs
Build and continuously refine the regional business plan in partnership with cross-functional teams, adjusting priorities as sites move through licensing, readiness, and activation
Act as an integral part of the national commercial leadership team, representing regional insights and escalating systemic issues (site operations, referral disruptions, supply) that affect launch execution
Team Leadership
Direct RTM activity and account coverage decisions in service of regional performance targets
Hire, coach, and develop a team of 6 to 9 RTMs drawn from a nonstandard talent pool spanning RLT/nuclear medicine and traditional pharma commercial backgrounds
Set differentiated coaching plans given inconsistent baseline skill sets across the team; run regular pipeline reviews, joint account visits, and account strategy sessions
Build best in class, diverse teams through structured onboarding, performance management, and succession planning
Maintain a minimum of 60 to 70 percent of time in the field, including joint calls with RTMs and direct engagement with business critical accounts
Cross-Functional Orchestration
Partner with Medical Affairs and Market Access peers as a credible commercial counterpart to triage site level bottlenecks escalated by RTMs
Coordinate with Medical Affairs on referral pathway education and with Sales Operations on shipment timing when either affects a scheduled patient dose
AI and Advanced Analytics Adoption
Leverage advanced analytics and AI tools to inform coaching, surfacing individual RTM performance patterns and tailoring development plans to each rep's strengths and gaps
Apply AI-enabled tools to territory and account planning, using data driven insights to prioritize site engagement and referral pathway development
Champion adoption of new analytics and AI capabilities across the team as they roll out, ensuring RTMs are using available tools consistently rather than defaulting to manual approaches
Requirements
Must-have:
7 to 10+ years pharma/biotech commercial leadership, including 3+ years as an RBD, Regional Director, or equivalent regional leadership role
Proven experience managing a team of 6+ direct reports in a field based commercial role
Direct launch experience in an access constrained model such as radioligand therapy, CAR-T, gene therapy, or similarly restricted network product
Track record of cross-functional leadership through influence with Medical Affairs, Market Access, or Sales Operations, rather than direct authority
Comfort adopting and championing analytics or AI enabled tools within a field team
Willingness and ability to maintain a high field presence (60 to 70 percent), including hands-on account planning for business critical accounts
Strongly preferred:
Prior RBD or equivalent role specifically on RPT
Existing regional relationships within the neuroendocrine tumor or nuclear medicine community
Clinical or technical background that adds credibility in RAM licensing or site readiness conversations
We hire for skills and capabilities, not just credentials – if this role excites you, but doesn’t perfectly match your resume, we encourage you to apply anyway.
Compensation Overview:
Field - United States - US: $243,870 - $295,507&#xa;
The starting pay range(s) listed above is for full-time employees (FTE). You may also be eligible for additional discretionary incentive cash and stock opportunities. We determine starting pay thoughtfully – carefully considering the nature of the role, required skills, work location, schedule and the knowledge and experience you bring. Final compensation is guided by pay equity principles and applicable employment laws. Compensation programs are reviewed on an ongoing basis and may be adjusted over time to reflect evolving market factors, and individual, team or Company performance.
Benefits:
Subject to the terms and conditions of the applicable plans then in effect, you may be eligible to participate in our comprehensive benefit plans – including wellbeing support, retirement and financial protection benefits, and insurance offerings (medical, dental, vision, life and disability).
U.S.-based exempt employees are eligible for Flexible Time Off (FTO), which provides paid time off without a set accrual limit, subject to manager approval, along with 11 paid company holidays each year.
Non-exempt employees, RayzeBio employees, and employees located in

> History, not a promise: past H-1B filings do not mean an employer will sponsor you or a given role. Data: U.S. DOL OFLC LCA disclosure (FY2024–FY2026 for role counts, certified LCAs) and the USCIS H-1B Employer Data Hub. Not legal advice. Methodology: https://visajobs.io/methodology
